CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioPharma Dive
High ImpactOriginal article

Telix buys ITM in bid to create a ‘radiopharmaceutical powerhouse’

Positive
AI Analysis

Summary

Telix is acquiring ITM for $1.65 billion upfront to combine their radiopharmaceutical pipelines and manufacturing networks. The deal aims to establish Telix as a dominant player in the radiopharmaceutical industry.

Importance:8/10
Sentiment:
0.70
M&Aradiopharmaceuticalsacquisitionpipeline consolidation
Related Companies

Read the original article

Published by BioPharma Dive on September 21, 2026 11:49 AM

Read Original